top of page
AdobeStock_352149697.jpeg

OMT for the Prevention and Management of Chronic Constipation and Distal Intestinal Obstructive Syndrome in Cystic Fibrosis: A Pilot Study

Cite

Full Text Link

Books and documents

-

Osteopathic Manipulative Treatment,Visceral and pregnancy,Fascial

J Am Osteopath Assoc. 2019 Jul 1;119(7):e31-e35.

Authors:

Sara E Modlin, Kristian Borofka, Danielle Franzini, Alaina C Klene-Bowns, Victor A Nuño

Abstract.



Context: Cystic fibrosis (CF) is an autosomal recessive genetic disorder primarily affecting the lungs and digestive system. Patients with CF often have multiorgan dysfunction, including chronic lung infections, pancreatic insufficiency, chronic constipation, and distal intestinal obstructive syndrome (DIOS).

Objective: To understand the impact of osteopathic manipulative treatment (OMT) on the prevention and management of gastrointestinal symptoms in patients with CF.

Methods: This study used OMT for physical manipulation of the viscera, spine, and other somatic components to improve bowel symptoms and prevent DIOS. These effects were achieved by releasing myofascial restrictions found in the abdomen and somatic structures with the intent to optimize the autonomic and lymphatic systems and improve range of motion.

Results: Four of 5 participants had a decrease in pain, and 3 participants had a reduced need for laxatives during treatment. Four participants had an overall increase in satisfaction with their bowel movements while being treated with OMT.

Conclusion: These findings support the use of OMT as a method for the management of chronic constipation and DIOS in the CF population. However, because of the small population size, more research with larger populations is needed.

Publication Date: 

2019 Jul

OEID: 

3195

Modlin, ES., Borofka, K., Franzini, D., Klene-bowns, CA., Nuño, AV. (2019) 'OMT for the Prevention and Management of Chronic Constipation and Distal Intestinal Obstructive Syndrome in Cystic Fibrosis: A Pilot Study', J Am Osteopath Assoc. 2019 Jul 1;119(7):e31-e35.

Sponsored by 

logo-footer-k.png

Search    Explore    About    Join    Web Policy     Contact Us

Copyright © 2023 OsteoEvidence. All Rights Reserved.
 

bottom of page